Bristol-Myers Squibb Co (BMY)
55.22
+0.90
(+1.66%)
USD |
NYSE |
Nov 04, 13:10
Bristol-Myers Squibb Debt to Equity Ratio: 2.902 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.902 |
| June 30, 2024 | 3.079 |
| March 31, 2024 | 3.376 |
| December 31, 2023 | 1.351 |
| September 30, 2023 | 1.297 |
| June 30, 2023 | 1.178 |
| March 31, 2023 | 1.189 |
| December 31, 2022 | 1.266 |
| September 30, 2022 | 1.197 |
| June 30, 2022 | 1.290 |
| March 31, 2022 | 1.424 |
| December 31, 2021 | 1.239 |
| September 30, 2021 | 1.202 |
| June 30, 2021 | 1.227 |
| March 31, 2021 | 1.231 |
| December 31, 2020 | 1.340 |
| September 30, 2020 | 0.8961 |
| June 30, 2020 | 0.9507 |
| March 31, 2020 | 0.9358 |
| December 31, 2019 | 0.9057 |
| September 30, 2019 | 1.414 |
| June 30, 2019 | 1.556 |
| March 31, 2019 | 0.3953 |
| December 31, 2018 | 0.5238 |
| September 30, 2018 | 0.5357 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.5997 |
| March 31, 2018 | 0.6019 |
| December 31, 2017 | 0.6781 |
| September 30, 2017 | 0.5711 |
| June 30, 2017 | 0.559 |
| March 31, 2017 | 0.585 |
| December 31, 2016 | 0.4147 |
| September 30, 2016 | 0.4372 |
| June 30, 2016 | 0.4515 |
| March 31, 2016 | 0.4657 |
| December 31, 2015 | 0.4689 |
| September 30, 2015 | 0.4824 |
| June 30, 2015 | 0.4873 |
| March 31, 2015 | 0.4797 |
| December 31, 2014 | 0.5273 |
| September 30, 2014 | 0.5064 |
| June 30, 2014 | 0.5048 |
| March 31, 2014 | 0.4943 |
| December 31, 2013 | 0.5503 |
| September 30, 2013 | 0.4897 |
| June 30, 2013 | 0.5014 |
| March 31, 2013 | 0.5779 |
| December 31, 2012 | 0.5428 |
| September 30, 2012 | 0.5294 |
| June 30, 2012 | 0.3382 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.8961
Minimum
Sep 2020
3.376
Maximum
Mar 2024
1.474
Average
1.235
Median
Debt to Equity Ratio Benchmarks
| Amgen Inc | 8.024 |
| Johnson & Johnson | 0.5096 |
| Eli Lilly and Co | 2.185 |
| Merck & Co Inc | 0.8671 |
| Pfizer Inc | 0.7831 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 93.67B |
| Total Liabilities (Quarterly) | 76.47B |
| Shareholders Equity (Quarterly) | 17.14B |
| Current Ratio | 1.240 |
| Net Debt Paydown Yield | -2.30% |